ARHGEF9 and central nervous system cancer: Subsequently, we investigated the levels of 6 proteins connected with the PI3K/AKT/mTOR pathway in ARHGEF9-treated glioma cells and discovered the levels of p-PIK3K, p-AKT, and p-mTOR were significantly downregulated.